Concealed effects of gene-environment interactions in genome-wide association

Multiple Sclerosis and Related Disorders

Volumn 1, Issue 1, 2012, Pages 39-42

  Handel, Adam E ^a,b   Williamson, Alexander J ^b   Ramagopalan, Sreeram V ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Gene environment interaction; Genetic epidemiology; Genome wide association study; Modelling; Multiple sclerosis; Vitamin D

Indexed keywords

EID: 80054699161     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2011.08.005     Document Type: Article

References (19)

1. De Jager PL, Simon KC, Munger KL, et al. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008;70:1113-8. (Pubitemid 351464768)
2. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics 2005;6:95-108. (Pubitemid 40179532)
3. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal of Medicine 2007;357: 851-62. (Pubitemid 47347319)
4. Handel AE, Ebers GC, Ramagopalan SV. Epigenetics: molecular mechanisms and implications for disease. Trends in Molecular Medicine 2009.
5. IMSGC. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies K1F21B and TMEM39A as susceptibility loci. Human Molecular Genetics 2010;19:953-62.
6. Islam T, Gauderman WJ, Cozen W, et al. Differential twin concordance for multiple sclerosis by latitude of birthplace. Annals of Neurology 2006;60:56-64.
7. Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene- environment interaction to detect genetic associations. Human Heredity 2007;63:111-9.
8. Khoury MJ, Wacholder S. 1nvited commentary: from genome-wide association studies to gene-environment-wide interaction studies-challenges and opportunities. American Journal of Epidemiology 2009;169:227-30. (discussion 234-5).
9. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. Journal of Clinical 1nvestigations 2008;118:1590-605. (Pubitemid 351632361)
10. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. (Pubitemid 44969183)
11. Murcray CE, Lewinger JP, Gauderman WJ. Gene-environment interaction in genome-wide association studies. American Journal of Epidemiology 2009;169: 219-26.
12. Nielsen TR, Rostgaard K, Askling J, et al. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Multiple Sclerosis 2009;15:431-6.
13. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurology 2010;9:727-39.
14. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class 11 Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics 2009;5:e1000369.
15. Simon KC, van der Mei IA, Munger KL, et al. Combined effects of smoking, anti- EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 2010;74:1365-71.
16. Simon KC, Munger KL, Xing Y, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis 2010;16: 133-8.
17. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annual Review of Public Health 2010;31:21-36.
18. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nature Reviews Genetics 2005;6:109-18. (Pubitemid 40179533)
19. Wang TT, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Molecular Endocrinology 2005;19:2685-95. ) (Pubitemid 41577243)